248
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Variant CD44 expression by human fibroblasts

, , , &
Pages 307-318 | Received 01 Jun 2007, Published online: 08 Oct 2008

References

  • Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zoller M. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992; 257: 682–685
  • Arlett CF, Green MH, Priestley A, Harcourt SA, Mayne LV. Comparative human cellular radiosensitivity: I. The effect of SV40 transformation and immortalisation on the gamma-irradiation survival of skin derived fibroblasts from normal individuals and from ataxia-telangiectasia patients and heterozygotes. International Journal of Radiation Biology 1988; 54: 911–928
  • Bloor BK, Jelvagharan M, White KN, Odell EW. Characterization of CD44 splicing patterns in normal keratinocytes, dysplastic and squamous carcinoma cell lines. International Journal of Oncology 2001; 18: 1053–1059
  • Bloor BK, Rajarajan A, Jaafary-Haghighat K, Odell EW. Transcription and expression of CD44 variant exons by oro-pharyngeal squamous cell carcinomas. International Journal of Oncology 2002; 21: 907–913
  • Croft DR, Dall P, Davies D, Jackson DG, McIntyre P, Kramer IM. Complex CD44 splicing combinations in synovial fibroblasts from arthritic joints. European Journal of Immunology 1997; 27: 1680–1684
  • Dall P, Heider KH, Hekele A, von Minckwitz G, Kaufmann M, Ponta H, Herrlich P. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Research 1994; 54: 3337–3341
  • Finn L, Dougherty G, Finley G, Meisler A, Becich M, Cooper DL. Alternative splicing of CD44 pre-mRNA in human colorectal tumors. Biochemical and Biophysical Research Communications 1994; 200: 1015–1022
  • Foekens JA, Dall P, Klijn JG, Skroch-Angel P, Claassen CJ, Look MP, Ponta H, Van Putten WL, Herrlich P, Henzen-Logmans SC. Prognostic value of CD44 variant expression in primary breast cancer. International Journal of Cancer 1999; 84: 209–215
  • Goodison S, Tarin D. Current status of CD44 variant isoforms as cancer diagnostic markers. Histopathology 1998; 32: 1–6
  • Goodison S, Yoshida K, Churchman M, Tarin D. Multiple intron retention occurs in tumor cell CD44 mRNA processing. American Journal of Pathology 1998; 153: 1221–1228
  • Green MH, Arlett CF, Cole J, Harcourt SA, Priestley A, Waugh AP, Stephens G, Beare DM, Brown NA, Shun-Shin GA. Comparative human cellular radiosensitivity: III. Gamma-radiation survival of cultured skin fibroblasts and resting T-lymphocytes from the peripheral blood of the same individual. International Journal of Radiation Biology 1991; 59: 749–765
  • Griffioen AW, Horst E, Heider KH, Wielenga VJ, Adolf GR, Herrlich P, Pals ST. Expression of CD44 splice variants during lymphocyte activation and tumor progression. Cell Adhesion Communications 1994; 2: 195–200
  • Harlow E, Lane DP. Antibodies: a laboratory manual. Cold Spring Harbour. Cold Spring Harbour Laboratory Press, New York 1989
  • Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor CD44: multiple functions, multiple forms. Cancer Cells 1991; 3: 347–350
  • Haynes BF, Telen MJ, Hale LP, Denning SM. CD44 – a molecule involved in leukocyte adherence and T-cell activation. Immunology Today 1989; 10: 423–428
  • Heider KH, Hofmann M, Hors E, Van den Berg F, Ponta H, Herrlich P, Pals ST. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. Journal of Cell Biology 1993; 120: 227–233
  • Herrera-Gayol A, Jothy S. Adhesion proteins in the biology of breast cancer: contribution of CD44. Experimental and Molecular Pathology 1999; 66: 149–156
  • Hirano F, Hirano H, Hino E, Takayama S, Saito K, Kusumoto Y, Shimabukuro Y, Murakami S, Okada H. CD44 isoform expression in periodontal tissues: cell-type specific regulation of alternative splicing. Journal of Periodontal Research 1997; 32: 634–645
  • Hudson D L, Sleeman J, Watt FM. CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. Journal of Cell Science 1995; 108: 1959–1970
  • Hudson DL, Speight PM, Watt FM. Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them. International Journal of Cancer 1996; 66: 457–463
  • Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. Journal of Cell Biochemistry 2007; 101: 805–815
  • Martegani MP, Del PF, Gasbarri A, Natali PG, Bartolazzi A. Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products. American Journal of Pathology 1999; 154: 291–300
  • Matsumura Y, Sugiyama M, Matsumura S, Hayle AJ, Robinson P, Smith JC, Tarin D. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. Journal of Pathology 1995; 177: 11–20
  • Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992; 340: 1053–1058
  • Mersmann M, Schmidt A, Rippmann JF, Wuest T, Brocks B, Rettig WJ, Garin-Chesa P, Pfizenmaier K, Moosmayer D. Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas. International Journal of Cancer 2001; 92: 240–248
  • Miyake H, Eto H, Arakawa S, Kamidono S, Hara I. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer. Journal of Urology 2002; 167: 1282–1287
  • Mueller MM, Fusenig NE. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation 2002; 70: 486–497
  • Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Advances in Cancer Research 1997; 71: 241–319
  • Ni HM, Leong AF, Cheong D, Hooi S. Expression of CD44 variants in colorectal carcinoma quantified by real-time reverse transcriptase-polymerase chain reaction. Journal of Laboratory & Clinical Medicine 2002; 139: 59–65
  • Patel V, Jakus J, Harris CM, Ensley JF, Robbins KC, Yeudall WA. Altered expression and activity of G1/S cyclins and cyclin-dependent kinases characterize squamous cell carcinomas of the head and neck. International Journal of Cancer 1997; 73: 551–555
  • Pedersen TX, Pennington CJ, Almholt K, Christensen IJ, Nielsen BS, Edwards DR, Romer J, Dano K, Johnsen M. Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas. Carcinogenesis 2005; 26: 1233–1240
  • Shtivelman E, Bishop JM. Expression of CD44 is repressed in neuroblastoma cells. Molecular & Cell Biology 1991; 11: 5446–5453
  • Sugino T, Yoshida K, Zhao S, Goodison S, Tarin D. Disorderly CD44 gene expression in human cancer cells can be modulated by growth conditions. Journal of Pathology 1998; 186: 17–23
  • Tahtis K, Lee FT, Wheatley JM, Garin-Chesa P, Park JE, Smyth FE, Obata Y, Stockert E, Hall CM, Old LJ, Rettig WJ, Scott AM. Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model. Molecular Cancer Therapeutics 2003; 2: 729–737
  • Tanabe KK, Ellis LM, Saya H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 1993; 341: 725–726
  • Tarin D, Matsumura Y. Deranged activity of the CD44 gene and other loci as biomarkers for progression to metastatic malignancy. Journal of Cell Biochemistry Supplement 1993; 17G: 173–185
  • Wibulswas A, Croft D, Bacarese-Hamilton I, McIntyre P, Genot E, Kramer IM. The CD44v7/8 epitope as a target to restrain proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. American Journal of Pathology 2000; 157: 2037–2044
  • Wibulswas A, Croft D, Pitsillides AA, Bacarese-Hamilton I, McIntyre P, Genot E, Kramer IM. Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints. Arthritis & Rheumatism 2002; 46: 2059–2064
  • Woodman AC, Sugiyama M, Yoshida K, Sugino T, Borgya A, Goodison S, Matsumura Y, Tarin D. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms. American Journal of Pathology 1996; 149: 1519–1530
  • Yoshida K, Bolodeoku J, Sugino T, Goodison S, Matsumura Y, Warren BF, Toge T, Tahara E, Tarin D. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. Cancer Research 1995; 55: 4273–4277
  • Zhang J, Madden TL. PowerBLAST: a new network BLAST application for interactive or automated sequence analysis and annotation. Genome Research 1997; 7: 649–656
  • Zhou J, Haggerty JG, Milstone LM. Growth and differentiation regulate CD44 expression on human keratinocytes. In Vitro Cellular & Developmental Biology. Animal 1999; 35: 228–235

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.